Progesterone, the calm hormone: what it does, why it crashes, and what you can do about it

If estrogen is the hormone that builds, progesterone is the hormone that holds. It calms the brain. It thickens the uterine lining and prepares it for implantation. It raises body temperature. It produces a sedative neurosteroid that quiets the nervous system. And then, in the week before your period, it falls off a cliff and takes your mood, your sleep, and your sense of stability with it.

Progesterone is one of the most under-discussed hormones in women's health and one of the most consequential. This is the standalone deep-dive on it, with the breadth it deserves.

The basics: what progesterone is

Progesterone is a steroid hormone synthesised primarily by the corpus luteum, the temporary endocrine gland that forms from the empty follicle after ovulation. The adrenal glands and (in pregnancy) the placenta also produce progesterone, but in a typical cycle the corpus luteum is the dominant source.

The synthesis is short and elegant: cholesterol is converted to pregnenolone by an enzyme on the inner mitochondrial membrane, and pregnenolone is then converted to progesterone by 3β-hydroxysteroid dehydrogenase. The corpus luteum produces up to 40 mg of progesterone per day at peak luteal activity ^[1].

Progesterone acts through the progesterone receptor (PR), present in two main isoforms (PR-A and PR-B) with overlapping but distinct effects. Progesterone is also metabolised into other active compounds, most importantly allopregnanolone, which binds the GABA-A receptor and is responsible for much of progesterone's effect on the brain ^[2].

When progesterone is present

In a typical cycle:

• Days 1 to 13 (follicular phase): progesterone is low (less than 1 ng/mL). The follicle is developing; no corpus luteum exists yet
• Day 14 (ovulation): progesterone begins to rise as the LH surge initiates corpus luteum formation
• Days 15 to 22 (early to mid-luteal phase): progesterone rises rapidly, peaking around 10 to 25 ng/mL roughly 7 days after ovulation
• Days 23 to 28 (late luteal phase): if no pregnancy occurs, the corpus luteum dies, and progesterone drops sharply. This withdrawal is what triggers menstruation

If pregnancy occurs, the embryo signals the corpus luteum to keep producing progesterone for the first ~10 weeks. Around weeks 8 to 10, the placenta takes over, eventually producing hundreds of milligrams per day by the third trimester.

What progesterone actually does

Calming the brain

This is the most underappreciated function. Progesterone itself is mildly sedating, but its metabolite allopregnanolone is the main actor. Allopregnanolone is a positive allosteric modulator of the GABA-A receptor ^[2][3]. It binds at a different site from benzodiazepines and barbiturates but produces a similar net effect: it amplifies GABA's inhibitory (calming) signal in the brain.

At physiological concentrations, allopregnanolone increases GABA-mediated chloride influx by 7 to 10-fold ^[3]. This is a substantial effect. For most women, it produces real anxiolysis, mild sedation, and the inward, slower energy many women associate with the luteal phase.

For a minority of women (particularly those with PMDD), allopregnanolone has the paradoxical opposite effect: anxiety, irritability, agitation. The proposed mechanism is altered sensitivity of the GABA-A receptor δ-subunit (see our Hormones and mood article).

Preparing the uterus for implantation

After ovulation, progesterone transforms the endometrium from a proliferative state into a secretory, supportive tissue ready for embryo implantation ^[4]. This transformation, called decidualization, involves dramatic structural and biochemical changes in endometrial stromal cells ^[5].

Decidualization is initiated by sustained progesterone exposure (typically 8 to 10 days of corpus luteum activity), supported by cyclic AMP signalling within the endometrial cells ^[6]. The decidua is what the embryo embeds into if conception occurs. If no pregnancy occurs, progesterone withdraws, the decidual tissue breaks down, and menstruation begins.

Maintaining early pregnancy

Progesterone is the hormone of pregnancy maintenance. It prevents uterine contractions (by opposing oxytocin and inflammatory mediators), supports placental development, suppresses maternal immune rejection of the embryo, and stimulates uterine growth. Without sufficient progesterone, early pregnancy cannot be sustained.

This is why progesterone supplementation is sometimes prescribed in early pregnancy for women with recurrent pregnancy loss or in IVF cycles where the natural corpus luteum may be suppressed.

Body temperature

Progesterone raises basal body temperature by 0.3 to 0.7°C in the luteal phase ^[7]. This is the rise you see on a fertility tracking chart that confirms ovulation has occurred. The mechanism likely involves both direct effects on hypothalamic thermoregulation and indirect effects via metabolic rate.

The temperature rise has consequences for sleep (see our luteal sleep article) and exercise (see our training article).

Breast tissue

Progesterone promotes glandular development in breast tissue, working with estrogen. The premenstrual breast tenderness many women experience reflects this tissue response to the progesterone (and estrogen) of the luteal phase. The discomfort resolves when both hormones withdraw at the start of menstruation.

Bone

Progesterone has been shown to stimulate osteoblasts (bone-building cells), complementing estrogen's restraint of osteoclasts (bone-breakdown cells). The relative contribution of progesterone versus estrogen to bone health is still being characterised in the research literature.

Other systemic effects

Progesterone affects breathing rate (increasing respiratory drive, particularly in pregnancy), gut motility (slowing it, contributing to luteal-phase bloating and constipation), bladder function, and lipid metabolism. The breadth is wider than most discussions acknowledge.

The crash: why the late luteal week is so hard

Progesterone does not gradually fade. It drops.

In the late luteal phase, if no pregnancy occurs, the corpus luteum undergoes regression (luteolysis). Progesterone levels can fall from peak (~15-25 ng/mL) to near-zero over 3 to 5 days. Allopregnanolone follows the same trajectory.

Two things happen as a result:

1. The endometrium loses its hormonal support and begins to shed. This is menstruation.
2. The GABA system suddenly loses its allopregnanolone support. The brain has been running on enhanced GABA tone for two weeks; the GABA-A receptors have adapted; the sudden withdrawal destabilises the calming signal. Sleep gets fragile. Mood vulnerability rises. Anxiety, irritability, and tearfulness can spike.

This is the late-luteal/PMS pattern. It is not a deficiency. It is a withdrawal.

The same mechanism, dramatically amplified, drives the postpartum period. During pregnancy, progesterone rises to 200 to 300 ng/mL (10 to 20 times the luteal-phase peak). Within hours of delivery, it crashes to less than 1 ng/mL. Allopregnanolone follows. The GABA system, which had adapted to high tonic neurosteroid support for nine months, is suddenly destabilised. The anxiety, mood lability, and sleep disturbance of the early postpartum period (and in severe cases, postpartum depression and postpartum psychosis) are mechanistically tied to this withdrawal .

Brexanolone (Zulresso), the first FDA-approved drug for postpartum depression, is essentially an allopregnanolone infusion. It works by replacing what postpartum withdrawal removed.

Luteal phase deficiency

Medical disclaimer. Luteal phase deficiency is a clinical entity in reproductive endocrinology with debated diagnostic criteria. The American Society of Reproductive Medicine 2021 committee opinion notes that LPD has not been definitively proven as an independent cause of infertility or recurrent pregnancy loss. Persistent short luteal phases, premenstrual spotting or difficulty conceiving warrant evaluation by a reproductive endocrinologist.

Some women produce inadequate progesterone in the luteal phase, a condition called luteal phase deficiency (LPD) or luteal phase defect ^[8]. Signs include:

• Cycles shorter than 26 days
• Luteal phase shorter than 10 days
• Premenstrual spotting starting 3 or more days before the full period
• Difficulty conceiving or recurrent early pregnancy loss

Important caveat from the American Society for Reproductive Medicine (ASRM) 2021 committee opinion: although progesterone is essential for implantation and early pregnancy, LPD has not been definitively proven as an independent cause of infertility or recurrent pregnancy loss ^[8]. The clinical entity exists; the diagnostic and therapeutic implications are debated. If your cycle pattern fits the description, this is worth discussing with a reproductive endocrinologist.

What this means for nutrition

Like estrogen, progesterone cannot be supplemented through food or non-prescription supplements. The body produces it from cholesterol; that production cannot be replaced or meaningfully amplified by nutrition.

What nutrition can do is support the systems progesterone acts on, particularly in the luteal phase:

• Magnesium in the luteal-phase variant of the nōuxx routine supports the nervous system that progesterone calms via allopregnanolone
• Vitamin B6 supports neurotransmitter synthesis (GABA, serotonin) that progesterone modulates
• Calcium has its own evidence for reducing PMS symptoms in the luteal phase
• L-tryptophan supports serotonin synthesis, which intersects with progesterone's mood effects

This is what cycle-synced supplementation actually does: not adding hormones, but supporting the nutrient infrastructure that interacts with the hormones the body produces.

What about chasteberry (Vitex agnus-castus)?

This is the herbal supplement most often promoted for "supporting progesterone." The evidence is genuinely mixed:

• Multiple clinical trials show modest improvement in PMS symptoms with Vitex extract ^[9][10]
• Proposed mechanism involves dopaminergic effects that reduce prolactin, which may indirectly support progesterone production
• However, recent reviews note that effects may be overestimated and methodology in many trials is limited ^[10]

The honest summary: Vitex is one of the better-supported herbal interventions for PMS, but the evidence quality is moderate, not strong. It is not in the nōuxx routine. Some women find it helpful; others do not. If you try it, give it 3 to 4 cycles and track symptoms.

For prescription-level progesterone interventions (micronized oral progesterone, transdermal progesterone, vaginal progesterone), these are medical decisions that require a doctor familiar with hormonal therapy.

Common questions

How do I know if my progesterone is low?

A serum progesterone test taken about 7 days after ovulation (sometimes called a "day 21 progesterone" in a 28-day cycle, adjusted for actual cycle length) reflects corpus luteum function. A level above 10 ng/mL generally suggests adequate ovulation. Lower levels can suggest LPD but interpretation requires context. Symptoms (short cycles, premenstrual spotting, difficulty conceiving) are often more clinically meaningful than a single number.

Can I increase my progesterone naturally?

Not meaningfully. The body's progesterone production is tied to ovulation. Improving ovulation quality (through addressing underlying conditions like PCOS or thyroid issues, supporting adequate nutrition and energy availability, reducing chronic stress, ensuring sufficient sleep) can indirectly improve progesterone production. There is no food, herb, or supplement that directly raises endogenous progesterone the way prescription progesterone does.

What about wild yam cream?

Wild yam contains diosgenin, a steroid that can be converted to progesterone in a laboratory but cannot be converted to progesterone in the human body. Wild yam cream does not increase your progesterone levels meaningfully. Compounded "natural progesterone" creams that actually do increase progesterone contain pharmaceutical progesterone derived from yam in a lab. This is a long-standing confusion in the wellness market.

Is bioidentical progesterone better than synthetic progestins?

Bioidentical progesterone (the same molecule the body produces) and synthetic progestins (modified molecules used in many contraceptives and hormone therapies) have different effects despite similar core function. Bioidentical micronized progesterone is generally better-tolerated, has stronger sedative effects (because it metabolises to allopregnanolone), and may have a different breast cancer risk profile than older synthetic progestins. This is a topic for a doctor familiar with hormone therapy.

Does progesterone cause weight gain?

Progesterone has mild effects on fluid retention and appetite that can cause modest premenstrual weight fluctuation (typically 1 to 2 kg of water), but it does not cause sustained weight gain in normal cyclical levels. Synthetic progestins used in some contraceptives can have different metabolic effects.

Can stress affect progesterone?

Yes. Chronic stress can suppress ovulation (and therefore progesterone production) through hypothalamic-pituitary-adrenal axis effects. The phenomenon is sometimes called "pregnenolone steal" in alternative medicine literature, where the body diverts cholesterol precursors toward cortisol production at the expense of sex hormone production. The actual biochemistry is more complex than this simple framing, but the clinical observation (chronic stress lowering progesterone via reduced ovulation) is supported.

Should I take progesterone for sleep?

For perimenopausal and postmenopausal women experiencing sleep disturbance, micronized oral progesterone at bedtime is an evidence-supported option that requires a prescription. For premenopausal women in a normal cycle, progesterone supplementation for sleep is generally not appropriate (it interferes with the cycle and is not necessary). The luteal-phase formulation of the nōuxx routine supports the nutrient infrastructure (magnesium, B vitamins) that interacts with the progesterone-allopregnanolone-GABA system without supplementing the hormone itself.

What happens to progesterone in perimenopause?

In perimenopause, ovulation becomes irregular. Some cycles are anovulatory (no ovulation, no corpus luteum, no progesterone). Other cycles have weakened corpus luteum function with shorter luteal phases and lower progesterone. The result: progesterone often becomes deficient relative to estrogen earlier in the menopause transition than estrogen itself declines. This is sometimes referred to as "low progesterone perimenopause" and is part of why sleep disturbance, mood symptoms, and heavy periods often appear in the late 30s and early 40s before estrogen itself drops dramatically.

The bottom line

Progesterone is the hormone of holding, calming, and supporting. It runs the luteal phase. It builds the conditions for pregnancy. It produces a neurosteroid that gives most women their late-cycle calm. And when it crashes (premenstrually, postpartum, perimenopausally), it takes mood, sleep, and stability with it.

Understanding progesterone is essential to understanding the back half of your cycle, the postpartum period, and the menopause transition. The cycle is not just the period. It is the rise and fall of progesterone as much as estrogen, and the way both interact with the brain, the uterus, and almost every system in between.

References

[1] McNatty KP. Follicular Determinants of Corpus Luteum Function in the Human Ovary. Advances in Experimental Medicine and Biology 1979. doi.org/10.1007/978-1-4684-3474-3_52

[2] Progesterone and Its Metabolites Play a Beneficial Role in Affect Regulation in the Female Brain. Pharmaceuticals (MDPI). mdpi.com/1424-8247/16/4/520

[3] Liang JJ, Rasmusson AM. Overview of the Molecular Steps in Steroidogenesis of the GABAergic Neurosteroids Allopregnanolone and Pregnanolone. Chronic Stress 2018;2. doi.org/10.1177/2470547018818555

[4] Devoto L, et al. The human corpus luteum: life cycle and function in natural cycles. Fertility and Sterility 2009;92(3):1067-1079. doi.org/10.1016/j.fertnstert.2008.07.1745

[5] Okada H, Tsuzuki T, Murata H. Decidualization of the human endometrium. Reproductive Medicine and Biology 2018;17(3):220-227. doi.org/10.1002/rmb2.12088

[6] Wetendorf M, DeMayo FJ. The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network. Molecular and Cellular Endocrinology 2012;357(1-2):108-18. doi.org/10.1016/j.mce.2011.10.028

[7] Baker FC, Siboza F, Fuller A. Temperature regulation in women: Effects of the menstrual cycle. Temperature (Austin, Tex.) 2020;7(3):226-262. doi.org/10.1080/23328940.2020.1735927

[8] Diagnosis and treatment of luteal phase deficiency: a committee opinion. Fertility and Sterility 2021;115(6):1416-1423. doi.org/10.1016/j.fertnstert.2021.02.010

[9] Schulte P. The Treatment of Premenstrual Syndrome With Preparations of Vitex Agnus Castus (Chaste-berry): a Systematic Review and Meta-analysis. 2017. doi.org/10.26226/morressier.5885d718d462b8028d891eed

[10] Chaste Tree (Vitex agnus-castus) for PMS/PMDD: What to Know Before You Try It (clinical review of trial evidence). secondary; primary trial body cited within. cp.care/chaste-tree-vitex-agnus-castus-for-pms-pmdd-what-to-know-before-you-try-it

[11] Lancel M, et al. Allopregnanolone Affects Sleep in a Benzodiazepine-Like Fashion. The Journal of Pharmacology and Experimental Therapeutics 1997;282(3):1213-1218. doi.org/10.1016/s0022-3565(24)36959-9

[12] Söderpalm AHV, et al. Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology 2004;29(3):339-354. doi.org/10.1016/s0306-4530(03)00033-7

[13] Yakin K, Hela F, Oktem O. Progesterone signaling in the regulation of luteal steroidogenesis. Molecular Human Reproduction 2023;29(8). doi.org/10.1093/molehr/gaad022

[14] Cleveland Clinic. Luteal Phase Defect: Causes, Symptoms and Treatment. Cleveland Clinic Health Library 2023. my.clevelandclinic.org/health/diseases/luteal-phase-defect

[15] Turkmen S, et al. Tolerance to allopregnanolone with focus on the GABA-A receptor. British Journal of Pharmacology 2011;162(2):311-27. doi.org/10.1111/j.1476-5381.2010.01059.x

[16] Reed BG, Carr BR. The Normal Menstrual Cycle and the Control of Ovulation. Endotext. Mdtext.com 2018. notion.so/36ccc438fea481c7bf5ef0cbf23a80e4